The objective of the ACCORDION study was to elucidate and clarify the long-term effects of the ACCORD treatment strategies, and provide additional data on the long-term relationships among various cardiovascular and diabetic risk factors.

Primary endpoints:

  • Composite outcome of death from cardiovascular causes
  • Nonfatal myocardial infarction
  • Nonfatal stroke

PHRI was the Canadian coordinating centre for the ACCORDION study, managing the 13 sites in Canada. Hertzel Gerstein was the Principal Investigator for Canada, and sat on the Steering Committee for ACCORD / ACCORDION studies.

Study Type

Interventional - Drug

Study Design

Prospective, observational follow-up

NO. of Countries


NO. of Sites


NO. of Participants


Study Period

2011 - 2015


National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute

Wake Forest School of Medicine

Back To Top